Biscayne Pharmaceuticals' Series B Round

Biscayne Pharmaceuticals raised a round of funding on January 27, 2017.

Biscayne Pharmaceuticals is a clinical stage biotechnology company developing drugs for difficult-to-treat conditions in two major disease areas: CNS disorders such as refractory epilepsy and drug-res…

Articles about Biscayne Pharmaceuticals' Series B Round: